BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15083407)

  • 1. [Reduced insulin effect in subclinical fatty liver].
    Thamer C; Machann J; Haap M; Bachmann O; Wietek B; Dahl D; Tschritter O; Fritsche A; Jacob S; Schick F; Stumvoll M; Häring H
    Dtsch Med Wochenschr; 2004 Apr; 129(16):872-5. PubMed ID: 15083407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
    Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
    Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies.
    Hwang JH; Stein DT; Barzilai N; Cui MH; Tonelli J; Kishore P; Hawkins M
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1663-9. PubMed ID: 17911339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.
    Chan DC; Watts GF; Ng TW; Hua J; Song S; Barrett PH
    Diabetes Obes Metab; 2006 Nov; 8(6):698-702. PubMed ID: 17026495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of liver fat on insulin clearance.
    Kotronen A; Vehkavaara S; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fat and lipid oxidation in humans.
    Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
    Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
    Kantartzis K; Machicao F; Machann J; Schick F; Fritsche A; Häring HU; Stefan N
    Clin Sci (Lond); 2009 Mar; 116(6):531-7. PubMed ID: 18980578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery.
    Phillips ML; Boase S; Wahlroos S; Dugar M; Kow L; Stahl J; Slavotinek JP; Valentine R; Toouli J; Thompson CH
    Diabetes Obes Metab; 2008 Aug; 10(8):661-7. PubMed ID: 17941875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins.
    Pietiläinen KH; Rissanen A; Kaprio J; Mäkimattila S; Häkkinen AM; Westerbacka J; Sutinen J; Vehkavaara S; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E768-74. PubMed ID: 15585588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of liver fat content to insulin resistance and metabolic syndrome].
    Yan HM; Gao X; Liu M; Gu Q; Zhang B; Li X
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1255-8. PubMed ID: 18844098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.
    Kotronen A; Peltonen M; Hakkarainen A; Sevastianova K; Bergholm R; Johansson LM; Lundbom N; Rissanen A; Ridderstråle M; Groop L; Orho-Melander M; Yki-Järvinen H
    Gastroenterology; 2009 Sep; 137(3):865-72. PubMed ID: 19524579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.
    Marsman HA; van Werven JR; Nederveen AJ; Ten Kate FJ; Heger M; Stoker J; van Gulik TM
    J Magn Reson Imaging; 2010 Jul; 32(1):148-54. PubMed ID: 20578022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
    Radetti G; Kleon W; Stuefer J; Pittschieler K
    Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.